TY - JOUR
T1 - Usefulness of left ventricular mass in predicting recovery of left ventricular systolic function in patients with symptomatic idiopathic dilated cardiomyopathy
AU - Naqvi, Tasneem Z.
AU - Goel, Rishi K.
AU - Forrester, James S.
AU - Davidson, Robert M.
AU - Siegel, Robert J.
N1 - Funding Information:
This study was supported in part by a grant from the Los Angeles Society of Echocardiography, Los Angeles, California. Manuscript received April 28, 1999; revised manuscript received and accepted September 28, 1999.
PY - 2000/3/9
Y1 - 2000/3/9
N2 - Prognosis of idiopathic dilated cardiomyopathy (IDC) is variable. We determined the prognostic value of left ventricular (LV) mass and systolic and diastolic function in patients with IDC of <12 months duration. Clinical and echocardiographic assessment was performed at baseline and at 8 ± 6 months follow-up in 25 patients (47 ± 13 years) with IDC and an LV ejection fraction (LVEF1) of <40% (22 ± 7%). Based on a follow-up LVEF (LVEF2) of < or >40%, patients were divided into unimproved (n = 13, LVEF2 = 21 ± 9%) and improved groups (n = 12, LVEF2 = 51 ± 11%). There was no difference in the LVEF1 (22 ± 8% vs 22 ± 6%), LV end-systolic (5.7 ± 0.8 vs 5.8 ± 0.9 cm) or end-diastolic (6.5 ± 0.6 vs 6.6 ± 0.9 cm) dimension, wall stress (102 ± 26 vs 99 ± 28 g/cm2), end-systolic (1.7 ± 0.3 vs 1.8 ± 0.2) or end-diastolic (1.7 ± 0.3 vs 1.6 ± 0.1) sphericity, dp/dt (582 ± 163 vs 678 ± 222 mm Hg/s), or right ventricular fractional shortening (20 ± 9% vs 27 ± 7%, p = 0.06) in unimproved and improved groups. LV mass was lower (1.00 ± 0.21 vs 1.38 ± 0.27 g/ml, p = 0007) and mitral inflow E-wave deceleration time shorter (97 ± 42 vs 164 ± 58 ms, p = 0007) in the unimproved versus the improved group. On Pearson correlation analysis, LV mass (r = 0.62, p = 0.001), deceleration time (r = 0.68, p = 0.0002), wall motion score index (r = -0.47, p = 02), and dp/dt (r = 0.52, p = 03) were the significant predictors of LVEF2. There was correlation between LV mass (grams per milliliter) and deceleration time (r = 0.61, p = 0.001). During follow-up, death occurred in 1, and readmission for worsening heart failure in 4 patients in the unimproved group versus no hospitalization in the improved group. Thus, in patients with recent onset IDC, LV mass and diastolic function determine late outcome.
AB - Prognosis of idiopathic dilated cardiomyopathy (IDC) is variable. We determined the prognostic value of left ventricular (LV) mass and systolic and diastolic function in patients with IDC of <12 months duration. Clinical and echocardiographic assessment was performed at baseline and at 8 ± 6 months follow-up in 25 patients (47 ± 13 years) with IDC and an LV ejection fraction (LVEF1) of <40% (22 ± 7%). Based on a follow-up LVEF (LVEF2) of < or >40%, patients were divided into unimproved (n = 13, LVEF2 = 21 ± 9%) and improved groups (n = 12, LVEF2 = 51 ± 11%). There was no difference in the LVEF1 (22 ± 8% vs 22 ± 6%), LV end-systolic (5.7 ± 0.8 vs 5.8 ± 0.9 cm) or end-diastolic (6.5 ± 0.6 vs 6.6 ± 0.9 cm) dimension, wall stress (102 ± 26 vs 99 ± 28 g/cm2), end-systolic (1.7 ± 0.3 vs 1.8 ± 0.2) or end-diastolic (1.7 ± 0.3 vs 1.6 ± 0.1) sphericity, dp/dt (582 ± 163 vs 678 ± 222 mm Hg/s), or right ventricular fractional shortening (20 ± 9% vs 27 ± 7%, p = 0.06) in unimproved and improved groups. LV mass was lower (1.00 ± 0.21 vs 1.38 ± 0.27 g/ml, p = 0007) and mitral inflow E-wave deceleration time shorter (97 ± 42 vs 164 ± 58 ms, p = 0007) in the unimproved versus the improved group. On Pearson correlation analysis, LV mass (r = 0.62, p = 0.001), deceleration time (r = 0.68, p = 0.0002), wall motion score index (r = -0.47, p = 02), and dp/dt (r = 0.52, p = 03) were the significant predictors of LVEF2. There was correlation between LV mass (grams per milliliter) and deceleration time (r = 0.61, p = 0.001). During follow-up, death occurred in 1, and readmission for worsening heart failure in 4 patients in the unimproved group versus no hospitalization in the improved group. Thus, in patients with recent onset IDC, LV mass and diastolic function determine late outcome.
UR - http://www.scopus.com/inward/record.url?scp=0034154912&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034154912&partnerID=8YFLogxK
U2 - 10.1016/S0002-9149(99)00822-X
DO - 10.1016/S0002-9149(99)00822-X
M3 - Article
C2 - 11078278
AN - SCOPUS:0034154912
SN - 0002-9149
VL - 85
SP - 624
EP - 629
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 5
ER -